Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
A8319 Dacomitinib (PF299804, PF299)Target: ErbBSummary: HER inhibitor
-
A8320 PF-00562271Target: FAK|Pyk2Summary: FAK/Pyk2 inhibitor,potent and ATP-competitive
-
A8322 Neratinib (HKI-272)1 CitationTarget: EGFRSummary: HER2/EGFR inhibitor,potent and irreversible
-
A8325 Tivantinib (ARQ 197)2 CitationTarget: METSummary: C-Met inhibitor,non-ATP-competitive
-
A8328 LDK378Target: ALKSummary: Potent ALK inhibitor
-
A8329 R42810 CitationSummary: Selective Axl inhibitor
-
A8332 R788 disodiumTarget: SykSummary: Syk inhibitor,ATP competitive and potent
-
A8345 PF-562271 HClTarget: FAK|Pyk2Summary: FAK/Pyk2 inhibitor
-
A8357 AG-1478Target: EGFRSummary: EGFR inhibitor,potent and selective
-
A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: IGF-IR/IR/ALK inhibitor, ATP-competitive